Home - Products - MAPK/ERK Signaling - ERK - Byakangelicol

Byakangelicol

CAS No. 26091-79-2

Byakangelicol( —— )

Catalog No. M18325 CAS No. 26091-79-2

Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	136	In Stock
5MG	128	In Stock
10MG	188	In Stock
25MG	330	In Stock
100MG	Get Quote	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Byakangelicol
Note

Research use only, not for human use.
Brief Description

Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions.
Description

Byakangelicol may inhibit P-gp expressed at the BBB even under in vivo conditions. Byakangelicol can inhibit IL-1beta-induced PGE2 release in A549 cells; this inhibition may be mediated by suppression of COX-2 expression and the activity of COX-2 enzyme, thus it may have therapeutic potential as an anti-inflammatory drug on airway inflammation.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

MAPK/ERK Signaling
Target

ERK
Recptor

COX-2
Research Area

——
Indication

——

Chemical Information

CAS Number

26091-79-2
Formula Weight

316.3
Molecular Formula

C17H16O6
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 50 mg/mL (158.07 mM)
SMILES

CC1(C(O1)COC2=C3C(=C(C4=C2OC(=O)C=C4)OC)C=CO3)C
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

BAY-885

BAY-885 (BAY885) is a highly potent, selective ERK5 (MAPK7) inhibitor with IC50 of 40 nM.
Tauroursodeoxycholic...

Tauroursodeoxycholic acid (TUDCA) is a neuroprotective bile conjugate; inhibits nuclear factor-kappa B (NF-κB) activation in glial cells.
AZD0364

AZD0364 (AZD-0364) is a potent, selective, orally active ERK1/2 inhibitor for treatment of NSCLC.

Sign In Join Free